Toll-like receptors and activation of autoreactive B cells.
Leadbetter
Elizabeth A
EA
Department of Microbiology, Boston University School of Medicine, Boston, Mass., USA.
Rifkin
Ian R
IR
Marshak-Rothstein
Ann
A
D000818:Animals; D000974:Antibodies, Antinuclear / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D002843:Chromatin / Q000276:immunology; D018899:CpG Islands / Q000276:immunology; D004268:DNA-Binding Proteins / Q000187:drug effects / Q000502:physiology*; D004195:Disease Models, Animal; D029721:Drosophila Proteins; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D008213:Lymphocyte Activation / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000502:physiology*; D051379:Mice; D019463:Mice, Inbred MRL lpr; D008822:Mice, Transgenic; D011947:Receptors, Antigen, B-Cell / Q000235:genetics; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000502:physiology*; D012217:Rheumatoid Factor / Q000235:genetics; D051217:Toll-Like Receptor 9; D051193:Toll-Like Receptors; D019014:fas Receptor / Q000235:genetics / Q000276:immunology
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D002843:Chromatin; D004268:DNA-Binding Proteins; D029721:Drosophila Proteins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008562:Membrane Glycoproteins; D011947:Receptors, Antigen, B-Cell; D011956:Receptors, Cell Surface; C495371:TLR9 protein, human; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9; D051193:Toll-Like Receptors; D019014:fas Receptor; D002738:Chloroquine; D012217:Rheumatoid Factor